Lymphoma Microenvironment in DLBCL and PTCL-NOS: the key to uncovering heterogeneity and the potential for stratification-Reference-Cited by-同舟云学术

Lymphoma Microenvironment in DLBCL and PTCL-NOS: the key to uncovering heterogeneity and the potential for stratification

Published:2022 Issue:3 Volume:62 Page:127-135
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:J Clin Exp Hematopathol

Author:

Miyawaki Kohta¹,Sugio Takeshi¹

Affiliation:

1. Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan

Publisher

Japanese Society for Lymphoreticular Tissue Research

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jslrt/62/3/62_22027/_pdf

Reference100 articles.

1. 1 Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, International Agency for Research on Cancer. 2017.

2. 2 Timmins MA, Wagner SD, Ahearne MJ. The new biology of PTCL-NOS and AITL: current status and future clinical impact. Br J Haematol. 2020; 189: 54-66.

3. 3 Sehn LH, Gascoyne RD. Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity. Blood. 2015; 125: 22-32.

4. 4 Reddy A, Zhang J, Davis NS et al. Genetic and functional drivers of diffuse large B cell lymphoma. Cell. 2017; 171: 481-494.e15.

5. 5 Chapuy B, Stewart C, Dunford AJ et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018; 24: 679-690.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic stratification in DLBCL patients with aberrant MYC gene;British Journal of Haematology;2024-08-13

2. Implementation of the recommended immunohistochemistry algorithm for classification of peripheral T‐cell lymphoma, not otherwise specified into the prognostically significant GATA3 and TBX21 subtypes;International Journal of Laboratory Hematology;2024-06-14

3. Programming Myeloid Cells with Chimeric Antigen Receptor Myeloid‐Based Therapies;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

4. Prognostic value of the peripheral blood lymphocyte/monocyte ratio combined with 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma;Current Problems in Cancer;2024-02

5. Precise diagnosis and treatment for peripheral T-cell lymphomas: From pathogenic mechanisms to innovative approaches;The Innovation Medicine;2024